[PHARMA] QoQ Annualized Quarter Result on 31-Mar-2012 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
03-May-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
31-Mar-2012 [#1]
Profit Trend
QoQ- 119.99%
YoY- 85.26%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Revenue 1,812,346 1,773,256 1,806,964 1,786,980 1,520,981 1,537,593 1,563,526 10.29%
PBT 103,313 132,088 141,146 171,820 73,186 75,757 82,344 16.24%
Tax -40,108 -37,856 -50,870 -55,576 -20,401 -21,620 -23,056 44.40%
NP 63,205 94,232 90,276 116,244 52,785 54,137 59,288 4.33%
-
NP to SH 61,710 92,860 88,796 114,740 52,157 53,620 58,808 3.24%
-
Tax Rate 38.82% 28.66% 36.04% 32.35% 27.88% 28.54% 28.00% -
Total Cost 1,749,141 1,679,024 1,716,688 1,670,736 1,468,196 1,483,456 1,504,238 10.52%
-
Net Worth 471,886 496,623 481,282 474,161 514,273 464,307 451,381 2.99%
Dividend
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Div 41,187 39,227 35,301 35,297 35,304 - - -
Div Payout % 66.74% 42.24% 39.76% 30.76% 67.69% - - -
Equity
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Net Worth 471,886 496,623 481,282 474,161 514,273 464,307 451,381 2.99%
NOSH 117,677 117,683 117,672 117,657 117,682 106,983 106,962 6.54%
Ratio Analysis
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
NP Margin 3.49% 5.31% 5.00% 6.51% 3.47% 3.52% 3.79% -
ROE 13.08% 18.70% 18.45% 24.20% 10.14% 11.55% 13.03% -
Per Share
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
RPS 1,540.10 1,506.80 1,535.58 1,518.79 1,292.44 1,437.23 1,461.75 3.52%
EPS 52.44 78.91 75.46 97.52 44.32 50.12 54.98 -3.09%
DPS 35.00 33.33 30.00 30.00 30.00 0.00 0.00 -
NAPS 4.01 4.22 4.09 4.03 4.37 4.34 4.22 -3.33%
Adjusted Per Share Value based on latest NOSH - 117,657
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
RPS 125.75 123.04 125.38 123.99 105.53 106.69 108.49 10.29%
EPS 4.28 6.44 6.16 7.96 3.62 3.72 4.08 3.22%
DPS 2.86 2.72 2.45 2.45 2.45 0.00 0.00 -
NAPS 0.3274 0.3446 0.3339 0.329 0.3568 0.3222 0.3132 2.98%
Price Multiplier on Financial Quarter End Date
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Date 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 -
Price 8.10 7.55 10.18 5.90 5.36 5.90 5.90 -
P/RPS 0.53 0.50 0.66 0.39 0.41 0.41 0.40 20.53%
P/EPS 15.45 9.57 13.49 6.05 12.09 11.77 10.73 27.37%
EY 6.47 10.45 7.41 16.53 8.27 8.49 9.32 -21.51%
DY 4.32 4.42 2.95 5.08 5.60 0.00 0.00 -
P/NAPS 2.02 1.79 2.49 1.46 1.23 1.36 1.40 27.54%
Price Multiplier on Announcement Date
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Date 18/02/13 06/11/12 08/08/12 03/05/12 22/02/12 01/11/11 10/08/11 -
Price 7.80 8.25 8.83 5.90 5.90 5.90 5.90 -
P/RPS 0.51 0.55 0.58 0.39 0.46 0.41 0.40 17.49%
P/EPS 14.87 10.46 11.70 6.05 13.31 11.77 10.73 24.17%
EY 6.72 9.56 8.55 16.53 7.51 8.49 9.32 -19.51%
DY 4.49 4.04 3.40 5.08 5.08 0.00 0.00 -
P/NAPS 1.95 1.95 2.16 1.46 1.35 1.36 1.40 24.59%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment